Grisanti Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$50K Hold
1,611
0.03% 44
2019
Q4
$60K Sell
1,611
-298
-16% -$10.6K 0.03% 54
2019
Q3
$65K Sell
1,909
-304
-14% -$11.1K 0.04% 50
2019
Q2
$91K Sell
2,213
-211
-9% -$8.38K 0.05% 49
2019
Q1
$98K Hold
2,424
0.06% 51
2018
Q4
$100K Hold
2,424
0.07% 44
2018
Q3
$101K Sell
2,424
-48,363
-95% -$1.86M 0.05% 49
2018
Q2
$1.75M Sell
50,787
-36,142
-42% -$1.24M 0.76% 33
2018
Q1
$2.93M Sell
86,929
-13,681
-14% -$470K 1.34% 26
2017
Q4
$3.46M Sell
100,610
-10,403
-9% -$355K 1.42% 26
2017
Q3
$3.76M Buy
111,013
+4,396
+4% +$141K 1.54% 23
2017
Q2
$3.4M Buy
106,617
+3,836
+4% +$121K 1.46% 23
2017
Q1
$3.34M Sell
102,781
-135,323
-57% -$4.27M 1.4% 23
2016
Q4
$7.34M Buy
238,104
+10,814
+5% +$330K 3.3% 14
2016
Q3
$7.3M Sell
227,290
-25,928
-10% -$867K 3.53% 16
2016
Q2
$8.46M Buy
253,218
+250,003
+7,776% +$7.98M 4.67% 12
2016
Q1
$90K Sell
3,215
-527
-14% -$15.1K 0.04% 46
2015
Q4
$114K Sell
3,742
-1,581
-30% -$49.7K 0.05% 37
2015
Q3
$158K Hold
5,323
0.06% 39
2015
Q2
$169K Hold
5,323
0.06% 41
2015
Q1
$175K Hold
5,323
0.07% 41
2014
Q4
$157K Hold
5,323
0.06% 48
2014
Q3
$149K Hold
5,323
0.06% 47
2014
Q2
$150K Hold
5,323
0.06% 45
2014
Q1
$162K Hold
5,323
0.07% 48
2013
Q4
$154K Hold
5,323
0.07% 45
2013
Q3
$145K Hold
5,323
0.07% 48
2013
Q2
$145K Buy
+5,323
New +$147K 0.07% 29

Other funds holding PFE

Grisanti Capital Management's PFE Position: Q1 2020 in Review

Grisanti Capital Management held its Pfizer (PFE) position steady in Q1 2020 at 1,611 shares worth $50K. The position accounts for 0.03% of the portfolio, ranked #44.

Grisanti Capital Management first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. The position peaked at $8.46M in Q2 2016. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Grisanti Capital Management held 1,611 shares of Pfizer worth $50K as of Q1 2020.
  • Grisanti Capital Management left its Pfizer share count unchanged in Q1 2020.
  • Pfizer made up 0.03% of Grisanti Capital Management's portfolio in Q1 2020, its #44 holding.
  • Grisanti Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • Grisanti Capital Management's Pfizer position peaked at $8.46M in Q2 2016.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Grisanti Capital Management's 13F filing for Q1 2020, filed 6 May 2020.